Ligand Pharmaceuticals, Inc. (LGND)
185.58
-1.44
(-0.77%)
USD |
NASDAQ |
Feb 11, 16:00
185.68
+0.10
(+0.05%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap : 3.653B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 296.13B |
| Johnson & Johnson | 580.30B |
| Elanco Animal Health, Inc. | 12.77B |
| Ionis Pharmaceuticals, Inc. | 13.66B |
| Krystal Biotech, Inc. | 7.906B |
Market Cap Related Metrics
| PE Ratio | 89.32 |
| PS Ratio | 14.54 |
| Price to Book Value | 3.844 |
| Price to Free Cash Flow | 178.77 |
| Price | 185.58 |
| Earnings Yield | 1.12% |
| Operating PE Ratio | 126.61 |
| Normalized PE Ratio | 822.24 |